Related Experiment Videos

Evolution of Left Ventricular Size in Late Survivors of Surgery for Hypoplastic Left Heart Syndrome

Markus Bjurbom1, Ajay J Iyengar2, Florian Moenkemeyer3

  • 1Department of Cardiac Surgery, Royal Children's Hospital, Melbourne, Victoria, Australia; Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

Insights

Aortic and mitral atresia predict worse outcomes in hypoplastic left heart syndrome patients after Fontan palliation, regardless of left ventricular size. Severe left ventricular hypoplasia impacts long-term Fontan outcomes.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Cardiac Surgery

Background:

  • Hypoplastic left heart syndrome (HLHS) poses significant risks, with aortic and mitral atresia being known early adverse event predictors.
  • The long-term impact of these atresias and associated left ventricular (LV) morphology on outcomes after Fontan palliation remains unclear.
  • Potential impairment of right ventricle (RV) function by a small, hypertrophied LV is a concern.

Purpose of the Study:

  • To investigate the long-term effects of aortic and mitral atresia in HLHS patients undergoing Fontan procedure.
  • To determine if a small, hypertrophied LV influences late adverse outcomes.
  • To assess the relationship between initial LV/RV length ratio and subsequent ventricular growth and clinical outcomes.

Main Methods:

  • Retrospective analysis of 30 HLHS patients surviving the Fontan procedure.
  • Echocardiographic data collected at birth, pre-Fontan, and post-Fontan (mean follow-up 10.9 years).
  • Key measurements included interventricular septum thickness, ventricular length, and calculation of the LV/RV length ratio at birth. Primary endpoint: death, transplantation, or Fontan takedown.

Main Results:

  • A LV/RV length ratio cutoff of 0.55 differentiated patient groups.
  • Group A (ratio ≤0.55) showed decreasing LV/RV ratio and septum thickness over time; Group B (ratio >0.55) remained static.
  • Aortic and mitral atresia were potent predictors of adverse late outcomes (death, transplant, takedown), independent of initial LV length (HR 8.5, p=0.029).

Conclusions:

  • Aortic and mitral atresia are associated with worse long-term outcomes post-Fontan in HLHS, irrespective of LV size or hypertrophy.
  • Severely hypoplastic LVs exhibit limited proportional growth compared to RVs.
  • These findings highlight the critical role of atresias in determining long-term prognosis in HLHS survivors.
Abstract

Related Concept Videos